Evidence map›Paper›PMID 31112547›Full record

ArticlePloS one2019

Effectiveness of the prevention of HIV mother -to-child transmission (PMTCT) program via early infant diagnosis (EID) data in Senegal.

Sokhna Bousso Gueye, Halimatou Diop-Ndiaye, Ousmane Diouf, Aissatou Sow-Ndoye, Fatoumata Touré, Ndèye Fatou Ngom-Faye, Diabou Diagne-Gueye, Khady Mbow-Ndiaye, Papa Amadou Niang Diallo, Aïssatou Gaye-Diallo and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sokhna Bousso GueyeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Halimatou Diop-NdiayeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Ousmane DioufLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Aissatou Sow-NdoyeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Fatoumata TouréLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Ndèye Fatou Ngom-FayeDivision de la Lutte contre le Sida et les IST (DLSI), Ministère de la Santé et de l'Action Sociale, Dakar, Senegal.
Diabou Diagne-GueyeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Khady Mbow-NdiayeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Papa Amadou Niang DialloConseil National de Lutte contre le Sida (CNLS), Primature, Dakar, Senegal.
Aïssatou Gaye-DialloLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Souleymane MboupLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Cheikh Tidiane NdourDivision de la Lutte contre le Sida et les IST (DLSI), Ministère de la Santé et de l'Action Sociale, Dakar, Senegal.
Cheikh Saad-Bouh BoyeLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Coumba Touré-KaneLaboratoire Bactériologie-Virologie, CHU Aristide Le Dantec, Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Cheikh Anta Diop University · SNInstitute of Health Research, Epidemiological Surveillance and Training · SNMinistère de la Santé Publique et Action Sociale · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo improve the care and treatment of HIV-exposed children, early infant diagnosis (EID) using dried blood spot (DBS) sampling has been performed in Senegal since 2007, making molecular diagnosis accessible for patients living in decentralized settings. This study aimed to determine the evolution of the HIV transmission rate in children from 2008 to 2015 and to analyze associated factors, particularly the mother's treatment status and/or child's prophylaxis status and the feeding mode.

methodsThe data were analyzed using EID reports from the reference laboratory. Information related to sociodemographic characteristics, HIV profiles, the mother's treatment status, the child's prophylaxis status, and the feeding mode was included. Descriptive statistics were calculated, and bivariate and multivariate logistic regression analyses were performed.

resultsDuring the study period, a total of 5418 samples (5020 DBS and 398 buffy coat) from 168 primary prevention of HIV mother-to-child transmission (PMTCT) intervention sites in Senegal were tested. The samples were collected from 4443 children with a median age of 8 weeks (1-140 weeks) and a sex ratio (M/F) of 1.1 (2309/2095). One-third (35.2%; N = 1564) of the children were tested before 6 weeks of age. Twenty percent (N = 885) underwent molecular diagnostic testing more than once. An increased number of mothers receiving treatment (57.4%; N = 2550) and children receiving prophylaxis (52.1%; N = 2315) for protection against HIV infection during breastfeeding was found over the study period. The transmission rate decreased from 14.8% (95% confidence interval (CI): 11.4-18.3) in 2008 to 4.1% (95% CI: 2.5-7.5) in 2015 (p < 0.001). However, multivariate logistic regression analysis revealed that independent predictors of HIV mother-to-child transmission included lack of mother's treatment (adjusted odd ratio (aOR) = 3.8, 95% CI: 1.9-7.7; p˂0.001), lack of child's prophylaxis (aOR = 7.8, 95% CI: 1.7-35.7; p = 0.009), infant age at diagnosis (aOR = 2.2, 95% CI: 1.1-4.3 for ≤6 weeks versus 12-24 weeks; p = 0.025) and protective effect of breastfeeding on ART against formula feeding (aOR = 0.4, 95% CI: 0.2, 0.7; p = 0.005).

conclusionThis study demonstrates the effectiveness of PMTCT interventions in Senegal but indicates also that increased efforts should be continued to reduce the MTCT rate to less than 2%.

Indexed as

Outcome Assessment, Health CarePregnancy Complications, InfectiousEarly DiagnosisFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMalePregnancyRiskSenegal

Identifiers

PMID31112547
PMCPMC6529000
OpenAlexW2945245559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.